0001678518-22-000002.txt : 20221122 0001678518-22-000002.hdr.sgml : 20221122 20221122121548 ACCESSION NUMBER: 0001678518-22-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221122 DATE AS OF CHANGE: 20221122 EFFECTIVENESS DATE: 20221122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lenz Therapeutics, Inc. CENTRAL INDEX KEY: 0001678518 IRS NUMBER: 901015551 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-380075 FILM NUMBER: 221408990 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE., SUITE #320 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 619-890-5125 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVE., SUITE #320 CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: PRESBYOPIA THERAPIES, INC. DATE OF NAME CHANGE: 20201030 FORMER COMPANY: FORMER CONFORMED NAME: PRESBYOPIA THERAPIES, LLC DATE OF NAME CHANGE: 20160629 D/A 1 primary_doc.xml X0708 D/A LIVE 0001678518 Lenz Therapeutics, Inc. 445 MARINE VIEW AVE., SUITE #320 DEL MAR CA CALIFORNIA 92014 619-890-5125 DELAWARE Presbyopia Therapies, LLC PRESBYOPIA THERAPIES, INC. PRESBYOPIA THERAPIES, LLC Corporation true Evert Schimmelpennink c/o Lenz Therapeutics, Inc. 445 Marine View Avenue, Suite 320 Del Mar CA CALIFORNIA 92014 Executive Officer Director Fred Guerard c/o Lenz Therapeutics, Inc. 445 Marine View Avenue, Suite 320 Del Mar CA CALIFORNIA 92014 Director James McCollum c/o Lenz Therapeutics, Inc. 445 Marine View Avenue, Suite 320 Del Mar CA CALIFORNIA 92014 Director Clare Ozawa c/o Lenz Therapeutics, Inc. 445 Marine View Avenue, Suite 320 Del Mar CA CALIFORNIA 92014 Director Zach Scheiner c/o Lenz Therapeutics, Inc. 445 Marine View Avenue, Suite 320 Del Mar CA CALIFORNIA 92014 Director Biotechnology Decline to Disclose 06b true 0001104659-20-122958 2020-10-30 true true true true false 0 49002348 49002348 0 Includes $46,999,991.15 new money; $251,192.63 conversion of debt; $1,751,164.25 upon the exercise of warrants false 45 0 0 0 false Lenz Therapeutics, Inc. /s/ Evert Schimmelpennink Evert Schimmelpennink President & CEO 2022-11-22